Related Experiment Video
Updated: Dec 7, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
FLASH Investigations Using Protons: Design of Delivery System, Preclinical Setup and Confirmation of FLASH Effect
Qixian Zhang1, Ethan Cascio1, Chengming Li1
1Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
FLASH (ultra-high dose rate) proton therapy shows potential for reduced normal tissue damage. This study developed a proton irradiation platform, achieving dose rates over 100 Gy/s for preclinical studies.
Area of Science:
- Medical Physics
- Radiation Oncology
- Preclinical Research
Background:
- Ultra-high dose rate irradiation, known as FLASH therapy, demonstrates reduced normal tissue toxicity compared to conventional dose rates.
- FLASH effects are observed at dose rates exceeding 40 Gy/s, with studies primarily using photon, electron, or some proton beams.
Purpose of the Study:
- To develop and characterize a proton irradiation platform for FLASH therapy within a clinical proton facility.
- To establish dosimetry methods for precise dose delivery at ultra-high dose rates.
- To investigate the potential tissue-sparing effects of FLASH proton therapy in preclinical models.
Main Methods:
- Development of a proton irradiation platform utilizing a double-scattering system in a clinical proton facility.
- Optimization of the scattering system to achieve a homogeneous dose distribution over a large field size at dose rates >100 Gy/s.
- Characterization of proton beam properties (energy, dose rate, field size) using dosimetry methods.
- Application of the developed platform for dose-response studies in mice undergoing partial abdominal irradiation.
Main Results:
- Successful development of a proton irradiation platform capable of delivering dose rates of approximately 120 Gy/s.
- Achieved a collimated pencil beam with a 1.6 × 1.2 cm2 elliptical field size.
- Preliminary results from mouse studies suggest a potential tissue-sparing effect associated with FLASH irradiation.
Conclusions:
- The developed proton irradiation platform enables FLASH radiotherapy research in a clinical setting.
- FLASH proton therapy holds promise for reducing normal tissue toxicity in radiation oncology.
- Further preclinical and clinical investigations are warranted to fully elucidate the benefits of FLASH proton therapy.
More Related Videos
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
10:48PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017